Anifrolumab for Adolescent Discoid Lupus Erythematosus

This case series describes the outcomes among adolescent patients with systemic lupus erythematosus and refractory discoid lupus erythematosus treated with anifrolumab.

Detalles Bibliográficos
Autores principales: Shaw, Katharina S., Rajeh, Ahmad, Le, Todd, Kahn, Philip J., Oza, Vikash S., Arkin, Lisa M., Vleugels, Ruth Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585408/
https://www.ncbi.nlm.nih.gov/pubmed/37851448
http://dx.doi.org/10.1001/jamanetworkopen.2023.38200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585408/
https://www.ncbi.nlm.nih.gov/pubmed/37851448
http://dx.doi.org/10.1001/jamanetworkopen.2023.38200

Ejemplares similares